New drug with AAV
Regenxbio’s treatment rgx-202 results for phase III was released. And they seem to be very promising. They are planing to apply to FDA for approval. They are using similar methods with Elevidys but with a new approach as I understand. What I am curious is, will they have similar pricing? It is not affordable. Does anyone have any idea?
u/byapici — 5 days ago